MiR-1260b inhibitor enhances the chemosensitivity of colorectal cancer cells to fluorouracil by targeting PDCD4/IGF1

Colorectal cancer (CRC) is the most common malignant tumor type and has become resistant to 5-fluorouracil (5-FU) in recent decades, which is one of the most popular therapies. Recently, microRNA (miRNA or miR) has been investigated as a potential therapeutic strategy for CRC. However, there has bee...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Jun, Cao, Jingjie, Zhou, Lurong, Du, Yunyi, Zhang, Xiaoling, Yang, Bo, Gao, Yangjun, Wang, Yu, Ma, Ning, Yang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6144919/
https://www.ncbi.nlm.nih.gov/pubmed/30250581
http://dx.doi.org/10.3892/ol.2018.9307

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6144919/
https://www.ncbi.nlm.nih.gov/pubmed/30250581
http://dx.doi.org/10.3892/ol.2018.9307

Ejemplares similares